Related references
Note: Only part of the references are listed.Anthocyanins Improve Hippocampus-Dependent Memory Function and Prevent Neurodegeneration via JNK/Akt/GSK3 Signaling in LPS-Treated Adult Mice
Muhammad Sohail Khan et al.
MOLECULAR NEUROBIOLOGY (2019)
Brain-Derived Neurotrophic Factor in Brain Disorders: Focus on Neuroinflammation
Bruno Lima Giacobbo et al.
MOLECULAR NEUROBIOLOGY (2019)
The endotoxin hypothesis of neurodegeneration
Guy C. Brown
JOURNAL OF NEUROINFLAMMATION (2019)
Juglanin ameliorates LPS-induced neuroinflammation in animal models of Parkinson's disease and cell culture via inactivating TLR4/NF-κB pathway
Fang-Xue Zhang et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Serum concentration and clinical significance of brain-derived neurotrophic factor in patients with Parkinson's disease or essential tremor
Yixian Huang et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2018)
Acute Neuroinflammatory Response in the Substantia Nigra Pars Compacta of Rats after a Local Injection of Lipopolysaccharide
Yazmin M. Flores-Martinez et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2018)
Unhealthy gut, unhealthy brain: The role of the intestinal microbiota in neurodegenerative diseases
Lindsay Joy Spielman et al.
NEUROCHEMISTRY INTERNATIONAL (2018)
Alternative microglial activation is associated with cessation of progressive dopamine neuron loss in mice systemically administered lipopolysaccharide
Eric E. Beier et al.
NEUROBIOLOGY OF DISEASE (2017)
Lipopolysaccharide-initiated persistent rhinitis causes gliosis and synaptic loss in the olfactory bulb
Sanae Hasegawa-Ishii et al.
SCIENTIFIC REPORTS (2017)
Inhibition of Rho-kinase by Fasudil protects dopamine neurons and attenuates inflammatory response in an intranasal lipopolysaccharide-mediated Parkinson's model
Qing He et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2016)
Protective Effect of Lupeol Against Lipopolysaccharide-Induced Neuroinflammation via the p38/c-Jun N-Terminal Kinase Pathway in the Adult Mouse Brain
Haroon Badshah et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2016)
Alkaloids from piper longum protect dopaminergic neurons against inflammation-mediated damage induced by intranigral injection of lipopolysaccharide
Huan He et al.
BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE (2016)
Cerebellar role in Parkinson's disease
Jasmine L. Mirdamadi
JOURNAL OF NEUROPHYSIOLOGY (2016)
Development of mature BDNF-specific sandwich ELISA
Yoon Lim et al.
JOURNAL OF NEUROCHEMISTRY (2015)
Impaired sense of smell and altered olfactory system in RAG-1-/- immunodeficient mice
Lorenza Rattazzi et al.
FRONTIERS IN NEUROSCIENCE (2015)
Neurodegeneration by Activation of the Microglial Complement-Phagosome Pathway
Liviu-Gabriel Bodea et al.
JOURNAL OF NEUROSCIENCE (2014)
Progression of Intestinal Permeability Changes and Alpha-Synuclein Expression in a Mouse Model of Parkinson's Disease
Leo P. Kelly et al.
MOVEMENT DISORDERS (2014)
Intranigral lipopolysaccharide induced anxiety and depression by altered BDNF mRNA expression in rat hippocampus
Lucian Hritcu et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2014)
Intranigral lipopolysaccharide administration induced behavioral deficits and oxidative stress damage in laboratory rats: Relevance for Parkinson's disease
Lucian Hritcu et al.
BEHAVIOURAL BRAIN RESEARCH (2013)
The Role of the Cerebellum in the Pathophysiology of Parkinson's Disease
Mechelle M. Lewis et al.
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES (2013)
NADPH oxidase and aging drive microglial activation, oxidative stress, and dopaminergic neurodegeneration following systemic LPS administration
Liya Qin et al.
GLIA (2013)
Autophagic Impairment Contributes to Systemic Inflammation-Induced Dopaminergic Neuron Loss in the Midbrain
Hui-Fen Zheng et al.
PLOS ONE (2013)
Intranasal LPS-Mediated Parkinson's Model Challenges the Pathogenesis of Nasal Cavity and Environmental Toxins
Qing He et al.
PLOS ONE (2013)
BDNF overexpression in mouse hippocampal astrocytes promotes local neurogenesis and elicits anxiolytic-like activities
G. Quesseveur et al.
TRANSLATIONAL PSYCHIATRY (2013)
Olfactory dysfunction in Parkinson disease
Richard L. Doty
NATURE REVIEWS NEUROLOGY (2012)
Treatment with a Substance P Receptor Antagonist Is Neuroprotective in the Intrastriatal 6-Hydroxydopamine Model of Early Parkinson's Disease
Emma Thornton et al.
PLOS ONE (2012)
Increased dopaminergic cells and protein aggregates in the olfactory bulb of patients with neurodegenerative disorders
Inaki-Carril Mundinano et al.
ACTA NEUROPATHOLOGICA (2011)
Increased Intestinal Permeability Correlates with Sigmoid Mucosa alpha-Synuclein Staining and Endotoxin Exposure Markers in Early Parkinson's Disease
Christopher B. Forsyth et al.
PLOS ONE (2011)
The progression of pathology in Parkinson's disease
Glenda Margaret Halliday et al.
YEAR IN NEUROLOGY 2 (2010)
Behavioral phenotyping of mouse models of Parkinson's disease
Tonya N. Taylor et al.
BEHAVIOURAL BRAIN RESEARCH (2010)
Glial cell line-derived neurotrophic factor protects midbrain dopaminergic neurons against lipopolysaccharide neurotoxicity
Bin Xing et al.
JOURNAL OF NEUROIMMUNOLOGY (2010)
Serum levels of brain-derived neurotrophic factor correlate with motor impairment in Parkinson's disease
Paula Scalzo et al.
JOURNAL OF NEUROLOGY (2010)
Missing pieces in the Parkinson's disease puzzle
Jose A. Obeso et al.
NATURE MEDICINE (2010)
Neuroinflammation in Parkinson's disease: Its role in neuronal death and implications for therapeutic intervention
Malu G. Tansey et al.
NEUROBIOLOGY OF DISEASE (2010)
Neuroinflammation in Parkinson's disease: a target for neuroprotection?
Etienne C. Hirsch et al.
LANCET NEUROLOGY (2009)
Mitochondrial import and accumulation of α-synuclein impair complex I in human dopaminergic neuronal cultures and Parkinson disease brain
Latha Devi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Parkinson's disease: clinical features and diagnosis
J. Jankovic
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2008)
From inflammation to sickness and depression: when the immune system subjugates the brain
Robert Dantzer et al.
NATURE REVIEWS NEUROSCIENCE (2008)
Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration
Liya Qin et al.
GLIA (2007)
A 100% increase of 687 dopaminergic cells in the olfactory bulb may explain hyposmia in Parkinson's disease
E Huisman et al.
MOVEMENT DISORDERS (2004)
Endotoxin: is it an environmental factor in the cause of Parkinson's disease?
I Niehaus et al.
OCCUPATIONAL AND ENVIRONMENTAL MEDICINE (2003)
Markers for dopaminergic neurotransmission in the cerebellum in normal individuals and patients with Parkinson's disease examined by RT-PCR
MJ Hurley et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2003)
Share Paper
